Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guérin-Naïve High-Risk Nonmuscle-Invasive Bladder CancerJ Urol 2022 Sep 01;208(3)589-599, IM McElree, RL Steinberg, AC Martin, J Richards, SL Mott, PT Gellhaus, KG Nepple, MA O'Donnell, VT Packiam
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.